181 related articles for article (PubMed ID: 38630775)
1. Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
Montagnoli DRABS; Leite VF; Godoy YS; Lafetá VM; Junior EAP; Chaurasia A; Aguiar MCF; Abreu MHNG; Martins RC
PLoS One; 2024; 19(4):e0302370. PubMed ID: 38630775
[TBL] [Abstract][Full Text] [Related]
2. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.
Grønhøj C; Jensen D; Dehlendorff C; Nørregaard C; Andersen E; Specht L; Charabi B; von Buchwald C
Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):375-381. PubMed ID: 29526405
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Parmar A; Macluskey M; Mc Goldrick N; Conway DI; Glenny AM; Clarkson JE; Worthington HV; Chan KK
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006386. PubMed ID: 34929047
[TBL] [Abstract][Full Text] [Related]
4. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.
Murphy CT; Galloway TJ; Handorf EA; Wang L; Mehra R; Flieder DB; Ridge JA
Cancer; 2015 Apr; 121(8):1204-13. PubMed ID: 25490875
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Oropharyngeal and Laryngeal Cancer Treatment Delay in a Private and Safety Net Hospital System.
Perlow HK; Ramey SJ; Silver B; Kwon D; Chinea FM; Samuels SE; Samuels MA; Elsayyad N; Yechieli R
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):484-493. PubMed ID: 29634400
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
Bulsara VM; Worthington HV; Glenny AM; Clarkson JE; Conway DI; Macluskey M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006205. PubMed ID: 30582609
[TBL] [Abstract][Full Text] [Related]
7. Oral cancer patient's profile and time to treatment initiation in the public health system in Rio de Janeiro, Brazil.
da Conceição MGD; Emmerick ICM; Figueiró AC; Luiza VL
BMC Health Serv Res; 2021 Feb; 21(1):145. PubMed ID: 33588852
[TBL] [Abstract][Full Text] [Related]
8. Oral and oropharyngeal cancer: time from first symptoms to treatment initiation and associated factors.
Costa AASD; Caldeira PC; Sousa AA; Tibúrcio JD; Belligoli LQG; Santos VBD; Bretas PMC; Nunes LL; Prado Neto SCD; Silva GW; Soares JMA
Braz Oral Res; 2023; 37():e054. PubMed ID: 37255074
[TBL] [Abstract][Full Text] [Related]
9. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
Ogura K; Fujiwara T; Healey JH
Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
[TBL] [Abstract][Full Text] [Related]
10. Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohort.
Frank MH; van Dijk BAC; Schoonbeek RC; Zindler J; Devriese LA; van Es RJJ; Merkx MAW; de Bree R
Radiother Oncol; 2024 Mar; 192():110107. PubMed ID: 38262531
[TBL] [Abstract][Full Text] [Related]
11. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
12. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
14. Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy.
Alexidis P; Kolias P; Mentesidou V; Topalidou M; Kamperis E; Giannouzakos V; Efthymiadis K; Bangeas P; Timotheadou E
Curr Oncol; 2023 May; 30(5):5168-5178. PubMed ID: 37232849
[TBL] [Abstract][Full Text] [Related]
15. Time-to-treatment initiation for cutaneous melanoma reflects disparities in healthcare access in Brazil: a retrospective study.
Pereira Shimada GD; Archanjo da Mota A; Carvalho de Souza M; Bernardes SS
Public Health; 2022 Sep; 210():1-7. PubMed ID: 35863157
[TBL] [Abstract][Full Text] [Related]
16. Mortality from oral and oropharyngeal cancer in Brazil: impact of the National Oral Health Policy.
Cunha ARD; Prass TS; Hugo FN
Cad Saude Publica; 2019; 35(12):e00014319. PubMed ID: 31800779
[TBL] [Abstract][Full Text] [Related]
17. Malignant neoplasms of the oral cavity and oropharynx treated in Brazil: what do hospital cancer records reveal?
Faria SO; Nascimento MCD; Kulcsar MAV
Braz J Otorhinolaryngol; 2022; 88(2):168-173. PubMed ID: 32682819
[TBL] [Abstract][Full Text] [Related]
18. [Performance of Brazilian municipalities in the supply of specialized oral health services].
Galvão MHR; Roncalli AG
Cad Saude Publica; 2021; 37(1):e00184119. PubMed ID: 33440412
[TBL] [Abstract][Full Text] [Related]
19. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach.
Carvalho AL; Magrin J; Kowalski LP
Oral Dis; 2003 May; 9(3):112-8. PubMed ID: 12945592
[TBL] [Abstract][Full Text] [Related]
20. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI
Cochrane Database Syst Rev; 2011 Apr; (4):CD006386. PubMed ID: 21491393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
